Citation Impact
Citing Papers
Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge
2009
Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells
2001
Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses
2008
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice
2023 StandoutNobel
Analysis of antibody-independent binding of dengue viruses and dengue virus envelope protein to human myelomonocytic cells and B lymphocytes
1998
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
Manipulation of cell surface macromolecules by flaviviruses
2003
Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses
2012
Biological activities and pharmaceutical applications of polysaccharide from natural resources: A review
2017 Standout
Intracellular Protein Delivery and Gene Transfection by Electroporation Using a Microneedle Electrode Array
2012
Dengue: defining protective versus pathologic immunity
2004
Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research
2003
Analysis of the Steps Involved in Dengue Virus Entry into Host Cells
1999
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Critical considerations for developing nucleic acid macromolecule based drug products
2015
Gene Electrotransfer: A Mechanistic Perspective
2016
Delivery of plasmid DNA expression vector for keratinocyte growth factor‐1 using electroporation to improve cutaneous wound healing in a septic rat model
2006
Electroporative transfection with KGF-1 DNA improves wound healing in a diabetic mouse model
2004
The promising alliance of anti-cancer electrochemotherapy with immunotherapy
2016
Lipid nanoparticles for mRNA delivery
2021 Standout
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
DNA electrotransfer into the skin using a combination of one high- and one low-voltage pulse
2005
Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery
2021 StandoutNobel
Chimeric Flaviviruses: Novel Vaccines against Dengue Fever, Tick-borne Encephalitis, and Japanese Encephalitis
2003
Enhanced Cutaneous Gene Delivery Following Intradermal Injection of Naked DNA in a High Ionic Strength Solution
2002
A Synthetic Erectile Optogenetic Stimulator Enabling Blue‐Light‐Inducible Penile Erection
2015
Induction of cytotoxic T-lymphocytes by electroporation-enhanced needle-free skin immunization
2005
Optogenetics: 10 years of microbial opsins in neuroscience
2015 Standout
DNA vaccine coding for the rhesus prostate specific antigen delivered by intradermal electroporation in patients with relapsed prostate cancer
2013
Gene Therapy Progress and Prospects: Nonviral vectors
2002
DNA vaccines: ready for prime time?
2008
Dengue 1 virus binding to human hepatoma HepG2 and simian Vero cell surfaces differs
1996
Growth restriction of dengue virus type 2 by site-specific mutagenesis of virus-encoded glycoproteins.
1998
Biomedical applications of biodegradable polymers
2011 Standout
Identification and Characterization of the Host Protein DNAJC14 as a Broadly Active Flavivirus Replication Modulator
2011 StandoutNobel
Patterns of Host Genome–Wide Gene Transcript Abundance in the Peripheral Blood of Patients with Acute Dengue Hemorrhagic Fever
2007
Dengue: a continuing global threat
2010 Standout
Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine
2010
Age‐dependent impairment of HIF‐1α expression in diabetic mice: Correction with electroporation‐facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells
2008 StandoutNobel
Electroporation enhances transfection efficiency in murine cutaneous wounds
2004
Energetics and dynamics of SNAREpin folding across lipid bilayers
2007 StandoutNobel
Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain
1996 StandoutNobel
Microneedles with Intrinsic Immunoadjuvant Properties: Microfabrication, Protein Stability, and Modulated Release
2010
An electrically active microneedle array for electroporation
2009
Transdermal drug delivery
2008 Standout
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
SNAREs — engines for membrane fusion
2006 Standout
Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses
2010
Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development
2010 StandoutNobel
Analysis of flavivirus envelope proteins reveals variable domains that reflect their antigenicity and may determine their pathogenesis
1995
Microneedle-Based Vaccines
2009
Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine
2002
Intradermal vaccine delivery: Will new delivery systems transform vaccine administration?
2008
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
Dengue Epidemiology: Virus Epidemiology, Ecology, And Emergence
2003
Antibodies that block virus attachment to vero cells are a major component of the human neutralizing antibody response against dengue virus type 2
1995
Dengue viremia in blood donors from Honduras, Brazil, and Australia
2008
Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
2019
A putative receptor for dengue virus in mosquito tissues: localization of a 45-kDa glycoprotein.
2002
Sar1p N-Terminal Helix Initiates Membrane Curvature and Completes the Fission of a COPII Vesicle
2005 StandoutNobel
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
In vivo electroporation enhances vaccine-mediated therapeutic control of human papilloma virus-associated tumors by the activation of multifunctional and effector memory CD8+ T cells
2017
Dengue
2012 Standout
Neglected Tropical Diseases in Sub-Saharan Africa: Review of Their Prevalence, Distribution, and Disease Burden
2009 Standout
Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and japanese encephalitis virus
2003
Micro-scale devices for transdermal drug delivery
2008
Localization of Dengue Virus in Naturally Infected Human Tissues, by Immunohistochemistry and In Situ Hybridization
2004
Expression and Purification of Dengue Virus Type 2 Envelope Protein as a Fusion with Hepatitis B Surface Antigen in Pichia pastoris
2001
Microneedles for drug and vaccine delivery
2012 Standout
Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus
2012 Standout
Immune Modulation by Adjuvants Combined with Diphtheria Toxoid Administered Topically in BALB/c Mice After Microneedle Array Pretreatment
2009
Molecular biology of flaviviruses
2003 StandoutNobel
Electroporation-enhanced delivery of nucleic acid vaccines
2014
Gold Nanoparticles for Biology and Medicine
2010 Standout
Dengue Virus Infects Macrophages and Dendritic Cells in a Mouse Model of Infection
2007
Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration
2021 StandoutNobel
Dengue virus life cycle: viral and host factors modulating infectivity
2010 Standout
Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses
2004
The Jak-STAT signaling pathway is required but not sufficient for the antiviral response of drosophila
2005 StandoutNobel
Microneedles for transdermal drug delivery: a minireview
2007
Enabling skin vaccination using new delivery technologies
2010
Dengue Vaccine Candidates in Development
2009
Hollow Microneedle Arrays for Intradermal Drug Delivery and DNA Electroporation
2010
The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell
2005
Human T Cell Response to Dengue Virus Infection
2019
rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and Highly Infectious in Healthy Adult Volunteers
2005
A high-capacity, hybrid electro-microneedle for in-situ cutaneous gene transfer
2011
Dengue diagnosis, advances and challenges
2004
The dawning era of polymer therapeutics
2003 Standout
Prospects for a dengue virus vaccine
2007
Photodynamic therapy – mechanisms, photosensitizers and combinations
2018 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Analysis of virus-cell binding characteristics on the determination of Japanese encephalitis virus susceptibility
1994
Cellular Immunology of Sequential Dengue Virus Infection and its Role in Disease Pathogenesis
2009
Dengue
2007 Standout
Rational design of anti‐inflammatory lipid nanoparticles for mRNA delivery
2022 StandoutNobel
Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates
2004
DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells
2003 StandoutNobel
Nanomaterial Delivery Systems for mRNA Vaccines
2021 StandoutNobel
Early T-Cell Responses to Dengue Virus Epitopes in Vietnamese Adults with Secondary Dengue Virus Infections
2005
Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta
2023 StandoutNobel
Utility of Humanized BLT Mice for Analysis of Dengue Virus Infection and Antiviral Drug Testing
2013 StandoutNobel
Dengue viral infections
2004
PHASE I TRIAL OF 16 FORMULATIONS OF A TETRAVALENT LIVE-ATTENUATED DENGUE VACCINE
2003
Tropism of Dengue Virus in Mice and Humans Defined by Viral Nonstructural Protein 3-Specific Immunostaining
2009
Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro
2012 StandoutNobel
Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver
2020
A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes inFlavivirus‐Naive Adults
2010
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Unmutated Immunoglobulin M Can Protect Mice from Death by Influenza Virus Infection
2003 StandoutNobel
Identification of two surface proteins from C6/36 cells that bind dengue type 4 virus
1997
Biological activities and potential health benefits of sulfated polysaccharides derived from marine algae
2010 Standout
Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4Δ30-4995 in Healthy Adult Volunteers
2009
Yellow fever 17D as a vaccine vector for microbial CTL epitopes
2005 StandoutNobel
Chemical Structures and Bioactivities of Sulfated Polysaccharides from Marine Algae
2011 Standout
Wound Healing Enhancement: Electroporation to Address a Classic Problem of Military Medicine
2005
MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells
2006
Genetic characterization of dengue virus type 1 isolated in Brunei in 2005–2006
2009
Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis
2006
Improvement in antigen-delivery using fabrication of a grooves-embedded microneedle array
2008
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
2023 StandoutNobel
Transfection by Electroporation
2003
Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody
2020 StandoutNobel
Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization
2009
PrM- and Cell-Binding Domains of the Dengue Virus E Protein
1999
Putative dengue virus receptors from mosquito cells
1998
Paired Charge-to-Alanine Mutagenesis of Dengue Virus Type 4 NS5 Generates Mutants with Temperature-Sensitive, Host Range, and Mouse Attenuation Phenotypes
2002
ANALYSIS OF RECOMBINANT DENGUE VIRUS POLYPEPTIDES FOR DENGUE DIAGNOSIS AND EVALUATION OF THE HUMORAL IMMUNE RESPONSE
2004
Protein-Lipid Interplay in Fusion and Fission of Biological Membranes
2003
Works of Alan King being referenced
Optimization of Skin Electroporation in Mice to Increase Tolerability of DNA Vaccine Delivery to Patients
2009
Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge
2006
Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers
2001
Correlation of E protein binding with cell susceptibility to dengue 4 virus infection
1992
Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation
2005
Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation
2010
Cutaneous Transfection and Immune Responses to Intradermal Nucleic Acid Vaccination Are Significantly Enhanced by in Vivo Electropermeabilization
2001
Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice
2000
Safety and Tolerability of the Easy Vax™ Clinical Epidermal Electroporation System in Healthy Adults
2011
B cells are the principal circulating mononuclear cells infected by dengue virus.
1999
SEROTYPE-SPECIFIC TH1 RESPONSES IN RECIPIENTS OF TWO DOSES OF CANDIDATE LIVE-ATTENUATED DENGUE VIRUS VACCINES
2003
High efficiency gene delivery into laryngeal muscle with bidirectional electroporation
2006
VACCINATION OF HUMAN VOLUNTEERS WITH MONOVALENT AND TETRAVALENT LIVE-ATTENUATED DENGUE VACCINE CANDIDATES
2003